Finepoint Capital’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$24.9M Buy
2024
Q2
$14.6M Buy
2024
Q1
$12.7M Buy
2023
Q4
$12.9M Buy
2023
Q3
$8.01M Buy
2023
Q2
$11.7M Sell
2023
Q1
$19.7M Sell
2022
Q4
$21.6M Sell
2022
Q3
$25.4M Buy
2022
Q2
$14.2M Buy